Sentinel Initiative Update: Brookings Roundtable on 6/20

FDA's Sentinel Initiative

Brookings Roundtable on Active Medical Product Surveillance
European Medicines Agency's Postmarket Drug Safety Activities: Overview of the Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsortiumWednesday, June 20, 2012 | 11:30 a.m. - 12:30 p.m. EDT
Live Webinar

Please join the upcoming webinar "European Medicines Agency's Postmarket Drug Safety Activities: Overview of the Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium" on Wednesday, June 20, 2012 from 11:30 a.m. to 12:30 p.m. EDT.

You must register to obtain this information.  Registration is limited to the first 300 registrants.

Coordinated by the European Medicines Agency, the Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) project was launched to stengthen the monitoring of the benefit-risk of medical products in Europe.  A methodological framework for the project is currently being developed through public and private partnerships.  This framework focuses on data collection and the early detection and assessment of adverse events.  Dr. Xavier Kurz, Principal Scientific Administrator at the Post-Authorisation, Pharmacovigilance, and Risk Management Sector of the European Medicines Agency, will provide an overview of this project.  Dr. Kurz will also discuss PROTECT's governance, innovative tools, methods that are currently being or have recently been developed, and the project's future direction.

Note: This roundtable will have an online webinar component to facilitate more interactive presentations and discussion.  As in past roundtables, it is still possile to participate only by teleconference.